Bottom line
How much do FHLC and LOGSX overlap?
31% of their top holdings overlap by weight. 13 securities appear in both funds' top 25, making up 43.1% of FHLC's assets and 50.3% of LOGSX's. They share a meaningful core but differ in the rest of the portfolio.
FHLC holds far more positions (337 vs 28), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings FHLC and LOGSX have in common
| Holding | % of FHLC | % of LOGSX | Overlap |
|---|---|---|---|
| Eli Lilly & Co | 13.35% | 1.99% | 1.99% |
| Johnson & Johnson | 8.93% | 3.77% | 3.77% |
| Merck & Co Inc | 4.66% | 3.16% | 3.16% |
| Amgen Inc | 3.00% | 4.86% | 3.00% |
| Gilead Sciences Inc | 2.34% | 3.50% | 2.34% |
| Bristol-Myers Squibb Co | 1.93% | 4.02% | 1.93% |
| Intuitive Surgical Inc | 1.82% | 2.99% | 1.82% |
| Vertex Pharmaceuticals Inc | 1.76% | 3.26% | 1.76% |
| McKesson Corp | 1.52% | 4.53% | 1.52% |
| Regeneron Pharmaceuticals Inc | 1.15% | 4.43% | 1.15% |
| Cigna Group/The | 1.06% | 3.46% | 1.06% |
| Cencora Inc | 0.83% | 4.46% | 0.83% |
| Cardinal Health Inc | 0.78% | 5.86% | 0.78% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in FHLC
- AbbVie Inc — 6.42%
- UnitedHealth Group Inc — 5.44%
- Thermo Fisher Scientific Inc — 3.09%
- Abbott Laboratories — 2.66%
- Pfizer Inc — 2.06%
- CVS Health Corp — 1.92%
- Danaher Corp — 1.80%
- Stryker Corp — 1.62%
- Medtronic PLC — 1.59%
- Elevance Health Inc — 1.19%
- Boston Scientific Corp — 1.00%
- HCA Healthcare Inc — 0.91%
Only in LOGSX
- N/a — 6.91%
- Jazz Pharmaceuticals Plc — 5.77%
- United Therapeutics Corp — 5.11%
- Exelixis Inc — 4.95%
- Lantheus Holdings Inc — 4.68%
- Novartis Ag — 4.67%
- National Healthcare Corp — 3.87%
- Medpace Holdings Inc — 3.69%
- Incyte Corp — 3.30%
- Medtronic Plc — 3.01%
- Novo Nordisk A/s — 2.51%
- Labcorp Holdings Inc — 2.29%
Asset mix
| Asset type | FHLC | LOGSX |
|---|---|---|
| Stocks | 99.7% | 97.2% |
| Repurchase agreements | — | 6.9% |
| Cash & short-term funds | 0.2% | 1.6% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Country mix
| Country | FHLC | LOGSX |
|---|---|---|
| US | 96.5% | 89.7% |
| IE | 2.2% | 8.8% |
| CH | 0.1% | 4.7% |
| DK | — | 2.5% |
| GB | 0.5% | — |
| BM | 0.2% | — |
| CA | 0.2% | — |
| NL | 0.1% | — |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do FHLC and LOGSX overlap?
What stocks do FHLC and LOGSX have in common?
Should I own both FHLC and LOGSX?
Which holds more stocks, FHLC or LOGSX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.